Heterogeneous Clearance of Antithymocyte Globulin after CD34+-Selected Allogeneic Hematopoietic Progenitor Cell Transplantation
Authors:
Open Access
- 1 August 2005
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (8) , 609-618
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantationTransplantation and Cellular Therapy, 2003
- Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell–depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor graftsTransplantation, 2003
- Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34+ enriched hematopoietic progenitor cells from partially mismatched related donorsBone Marrow Transplantation, 2002
- Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)Bone Marrow Transplantation, 2001
- Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)Blood, 2001
- STEM CELL TRANSPLANTATION ELIMINATES ALLOANTIBODY IN A HIGHLY SENSITIZED PATIENT1Transplantation, 2001
- Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment‐related mortality in stem cell transplantation from unrelated donors using pretransplantin vivoT‐cell depletion with anti‐thymocyte globulinBritish Journal of Haematology, 2001
- MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1Transplantation, 2001
- Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasiaBritish Journal of Haematology, 2000
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998